FASSIHI REZA 4
4 · SCOLR Pharma, Inc. · Filed Aug 28, 2006
Insider Transaction Report
Form 4
FASSIHI REZA
Director
Transactions
- Sale
Common Stock
2006-06-30$4.74/sh−600$2,844→ 6,967 total - Sale
Common Stock
2006-07-05$4.84/sh−700$3,388→ 67 total - Sale
Common Stock
2006-06-30$4.69/sh−2,500$11,725→ 22,767 total - Sale
Common Stock
2006-06-30$4.73/sh−1,600$7,568→ 7,567 total - Sale
Common Stock
2006-07-05$4.82/sh−600$2,892→ 1,167 total - Sale
Common Stock
2006-06-30$4.70/sh−3,600$16,920→ 19,167 total - Sale
Common Stock
2006-07-05$4.75/sh−200$950→ 3,767 total - Sale
Common Stock
2006-06-30$4.72/sh−2,400$11,328→ 9,167 total - Sale
Common Stock
2006-06-30$4.71/sh−7,600$35,796→ 11,567 total - Sale
Common Stock
2006-07-05$4.77/sh−1,000$4,770→ 2,767 total - Sale
Common Stock
2006-06-30$4.68/sh−500$2,340→ 25,267 total - Sale
Common Stock
2006-07-05$4.83/sh−400$1,932→ 767 total